Immune response to vaccination with DNA-Hsp65 in a phase I clinical trial with head and neck cancer patients (Q40004825)

16 September 2017

Immune response to vaccination with DNA-Hsp65 in a phase I clinical trial with head and neck cancer patients (English)

1 reference

16 September 2017

phase I clinical trial

0 references

1 reference

1 reference

head and neck carcinoma

1 reference

Carlos Rodrigo Zárate-Bladés

inferred from title

author

8

1 reference

16 September 2017

G D Victora

1

1 reference

16 September 2017

A Socorro-Silva

2

1 reference

16 September 2017

E C Volsi

3

1 reference

16 September 2017

K Abdallah

4

1 reference

16 September 2017

F D Lima

5

1 reference

16 September 2017

R B Smith

6

1 reference

16 September 2017

R A Moyses

7

1 reference

16 September 2017

P Michaluart

9

1 reference

16 September 2017

C L Silva

10

1 reference

16 September 2017

J Kalil

11

1 reference

16 September 2017

V Coelho

12

1 reference

16 September 2017

6 February 2009

1 reference

16 September 2017

1 reference

16 September 2017

16

1 reference

16 September 2017

7

1 reference

16 September 2017

598-608

1 reference

https://scigraph.springernature.com/pub.10.1038/cgt.2009.9

16 September 2017

0 references

cites work

Heat shock, stress proteins, chaperones, and proteotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

Molecular chaperones in the cytosol: from nascent chain to folded protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

Vaccination against tuberculosis by DNA injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

Therapy of tuberculosis in mice by DNA vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

In vivo gene therapy of malignant tumours with heat shock protein-65 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

Cellular autoreactivity against heat shock protein 60 in renal transplant patients: peripheral and graft-infiltrating responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

T-cell autoreactivity to Hsp in human transplantation may involve both proinflammatory and regulatory functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

Preclinical and clinical safety studies on DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

Gene-based vaccines: recent technical and clinical advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

DNA vaccines: recent developments and future possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

Mycobacterium tuberculosis chaperonin 60.1 is a more potent cytokine stimulator than chaperonin 60.2 (Hsp 65) and contains a CD14-binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

Correlates of protective immunity to Mycobacterium tuberculosis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

Immunobiology of head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

Heat-shock proteins induce T-cell regulation of chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

7 January 2021

Removal of endotoxin from protein solutions by phase separation using Triton X-114

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

7 January 2021

Immune regulatory effect of pHSP65 DNA therapy in pulmonary tuberculosis: activation of CD8+ cells, interferon-gamma recovery and reduction of lung injury

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

7 January 2021

Immune modulation induced by tuberculosis DNA vaccine protects non-obese diabetic mice from diabetes progression

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

7 January 2021

Immunomodulation and protection induced by DNA-hsp65 vaccination in an animal model of arthritis

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

7 January 2021

Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.9

7 January 2021

Identifiers

DOI

10.1038/CGT.2009.9

1 reference

Dimensions Publication ID

16 September 2017

0 references

1 reference